Open AccessWill Nano Medicine Prove to be a Game Changer in Diabetes?
Author(s) -
Faheem A. Sheikh,
Syed Mudassar
Publication year - 2014
Publication title -
journal of medical sciences/journal of medical sciences (srinagar. online)
Language(s) - English
Resource type - Journals
eISSN - 2582-063X
pISSN - 0972-110X
DOI - 10.33883/jms.v17i1.224
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , blindness , type 1 diabetes , insulin resistance , intensive care medicine , insulin , endocrinology , optometry
Diabetes is not one but 5 different complex disorders that arises from various causes, including dysregulated glucose sensing or insulin secretion (maturity-onset diabetes of the young, MODY), autoimmune-mediated β–cell destruction (type 1), or insufficient compensation for peripheral insulin resistance (type 2). Type 2 diabetes afflicts millions of people worldwide, the leading cause of blindness, kidney failure, and amputation among adults a major health problem that’s increasingly getting worse. However, with the advent of nanomedicine it has generated an immense interest among nanotechnologists, endocrinologists as well academic researchers, as it is imperative that effective monitoring and treatment options to be developed to successfully manage and control diabetes. JMS 2014;17(1):2-3